“互联网+手机APP”的药学服务在COPD患者健康管理中的作用研究

The Role of Pharmaceutical Service on Platform “Internet+ APP” in the Health Management of COPD Patients

目的:本研究以药师利用"互联网+手机APP"的技术平台参与COPD患者的健康管理为切入点,探讨在新医改形势下的药学延伸服务,明确药师干预在慢病患者用药方面的重要作用。方法:以患者用药依从性、临床疗效、安全性评价、医疗成本经济学评价为考核指标,应用SPSS(20.0)统计软件对数据进行处理,干预组和非干预组之间的差异性比较采用两个样本的秩和检验,以P<0.05为差异具有统计学意义。结果:干预组在用药依从性、临床疗效方面都明显优于非干预组(P=0.000,P<0.05),差异有统计学意义;在医疗经济成本方面,差异无统计学意义(P=0.636,P>0.05);对于用药期间所发生的不良反应,干预组也少于非干预组。结论:药师干预在慢阻肺患者的疾病康复、安全用药等方面有着很大作用,同时通过互联网的应用,加强了药学服务的深度和广度,提高了药师的公众认可度,为药师参与慢病管理找准了切入点,但是本研究具有一定的局限性,有待进一步改进。

Objective: This study starts with the pharmacists intervention in the health management of COPD patients relied on the technology platform "Internet + APP", The purpose is to explore the pharmaceutical extension services under the new medical reform situation, and clear the important role of pharmacist in participating the medication of patients with chronic diseases. Methods: The evaluation indicators are patient compliance, clinical efficacy, safety evaluation and medical cost economics evaluation. We used SPSS (20.0) to process the data. The rank sum test of two samples was used to compare the difference between the intervention group and the non-intervention group, with the statistically significant difference of P<0.05. Results: The intervention group was significantly superior to the non-intervention group in terms of drug compliance and clinical efficacy, and the difference was statistically significant (P=0.000,P<0.05);the difference of medical economic cost the is not statistically significant;The intervention group was also smaller than the non-intervention group in terms of adverse reactions during the period of medication. Conclusions: Pharmacists' intervention plays an important role in COPD patients' disease progression and safety. At the same time, the application of the internet has strengthened the depth and breadth of pharmaceutical services, improved the public recognition of pharmacists, and found a breakthrough point for pharmacists to participate in chronic disease management. However, this study has certain limitations, which need to be improved in the next step.